Clinical trial
AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC
NCT05247684
Study timeline
Study start (actual)2022-02-20Date precision: day
Registry last updated2026-07-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Resectable Non-small Cell Lung Cancerunresolved
Interventions
AK112DRUG
CarboplatinDRUG · verified · RxNorm: carboplatin
CisplatinDRUG · verified · RxNorm: cisplatin
PaclitaxelDRUG · verified · RxNorm: paclitaxel
Sponsors & collaborators
Akesolead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05247684 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.